KYONGBO PHARMACEUTICAL (214390) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, KYONGBO PHARMACEUTICAL (214390) reported revenue of 264.1 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025264.1 billion KRW3.5 billion KRW182 million KRW[source]
2024238.6 billion KRW10.5 billion KRW4.6 billion KRW[source]
2023216.4 billion KRW5.5 billion KRW3.0 billion KRW[source]
2022196.3 billion KRW1.4 billion KRW611 million KRW[source]
2021170.7 billion KRW-6.6 billion KRW-7.5 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025319.5 billion KRW173.8 billion KRW145.7 billion KRW[source]
2024283.9 billion KRW137.7 billion KRW146.2 billion KRW[source]
2023266.3 billion KRW121.9 billion KRW144.4 billion KRW[source]
2022240.5 billion KRW96.8 billion KRW143.7 billion KRW[source]
2021237.0 billion KRW91.3 billion KRW145.7 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice